Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04526210
Recruitment Status : Completed
First Posted : August 25, 2020
Last Update Posted : July 22, 2021
Sponsor:
Information provided by (Responsible Party):
Alexion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 19, 2021
Actual Study Completion Date : May 19, 2021